Suppression of mucin 2 enhances the proliferation and invasion of LS174T human colorectal cancer cells

Cell Biology International

Volumn 35, Issue 11, 2011, Pages 1121-1129

  Bu, Xiaodong ^a   Li, Li ^b   Tian, Xiaoqiang ^a   Huang, Peilin ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Cell invasion; Cell proliferation; Colorectum; MUC2; Mucin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GELATINASE B; KI 67 ANTIGEN; MUCIN 2; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOGENESIS; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSFECTION; GOBLET CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA INTERFERENCE; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; MUCIN-2; NEOPLASM INVASIVENESS; PLASMIDS; RNA INTERFERENCE; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 80054990191     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100876     Document Type: Article

References (37)

1. Aksoy N, Corfield AP, Sheehan JK. Preliminary study pointing out a significant alteration in the biochemical composition of MUC2 in colorectal mucinous carcinoma. Clin Biochem 2000;33:167-73.
2. Baldus SE, Wienand JR, Werner JP, Landsberg S, Drebber U, Hanisch FG et al. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope. Int J Oncol 2005;27:1289-97.
3. Barshishat M, Polak-Charcon S, Schwartz B. Butyrate regulates E- cadherin transcription, isoform expression and intracellular position in colon cancer cells. Br J Cancer 2000;82:195-203.
4. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:2073-87.
5. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004;23:77-99.
6. Carethers JM, Pham TT. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines. In Vivo 2000;14:13-20.
7. Chiang JM, Yeh CY, Changchien CR, Chen JS, Tang R, Chen JR. Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups. Int J Colorectal Dis 2010;25:941-7.
8. Haab BB, Porter A, Yue T, Li L, Scheiman J, Anderson MA et al. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann Surg 2010;251:937-45.
9. Hassan R, Schweizer C, Lu KF, Schuler B, Remaley AT, Weil SC et al. Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb- 009: implications for cancer therapy. Lung Cancer 2010;68:455-9.
10. Kang H, O9Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 2005;48:1161-8.
11. Kanoh A, Takeuchi H, Kato K, Waki M, Usami K, Irimura T. Interleukin-4 induces specific pp-GalNAc-T expression and alterations in mucin O-glycosylation in colonic epithelial cells. Biochim Biophys Acta 2008;1780:577-84.
12. Kasashima S, Kawashima A, Zen Y, Ozaki S, Kobayashi M, Tsujibata A et al. Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast. Virchows Arch 2007;450:397-403.
13. Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, Liu Z, Yamamoto H et al. WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer. Mod Pathol 2008;21:150-8.
14. Kazama Y, Watanabe T, Kanazawa T, Kazama S, Tada T, Tanaka J et al. Mucinous colorectal cancers with chromosomal instability: a biologically distinct and aggressive subtype. Diagn Mol Pathol 2006;15:30-4.
15. Kuan SF, Byrd JC, Basbaum CB, Kim YS. Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res 1987;47:5715-24.
16. Lee MJ, Lee HS, Kim WH, Choi Y, Yang M. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 2003;16:403-10.
17. Leopoldo S, Lorena B, Cinzia A, Gabriella DC, Angela Luciana B, Renato C et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol 2008;15:1429-39.
18. Li A, Goto M, Horinouchi M, Tanaka S, Imai K, Kim YS et al. Expression of MUC1 and MUC2 mucins and relationship with cell proliferative activity in human colorectal neoplasia. Pathol Int 2001;51:853-60.
19. Li YY, Hsieh LL, Tang RP, Liao SK, Yeh KY. Macrophage-derived interleukin-6 up-regulates MUC1, but down-regulates MUC2 expression in the human colon cancer HT-29 cell line. Cell Immunol 2009;256:19-26.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-8.
21. Maksimović S. Survival rates of patients with mucinous adenocarcinoma of the colorectum. Med Arh 2007;61:26-9.
22. Melis M, Hernandez J, Siegel EM, McLoughlin JM, Ly QP, Nair RM et al. Gene expression profiling of colorectal mucinous adenocarcinomas. Dis Colon Rectum 2010;53:936-43.
23. Morrison C, Merati K, Marsh Jr WL, De Lott L, Cohn DE, Young G et al. The mucin expression profile of endometrial carcinoma and correlation with clinical-pathologic parameters. Appl Immunohistochem Mol Morphol 2007;15:426-31.
24. Okudaira K, Kakar S, Cun L, Choi E, Wu Decamillis R, Miura S et al. MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues. Int J Oncol 2010;36:765-75.
25. Perez RO, Bresciani BH, Bresciani C, Proscurshim I, Kiss D, Gama-Rodrigues J et al. Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis. Int J Colorectal Dis 2008;23:757-65.
26. Sasaki M, Ikeda H, Nakanuma Y. Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. Prog Histochem Cytochem 2007;42:61-110.
27. Senapati S, Sharma P, Bafna S, Roy HK, Batra SK. The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histol Histopathol 2008;23:1541-52.
28. Takagawa M, Muguruma N, Oguri K, Imoto Y, Okamoto K, Ii K et al. Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry. Dig Dis Sci 2005;50:1410-3.
29. Tom BH, Rutzky LP, Jakstys MM, Oyasu R, Kaye CI, Kahan BD. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro 1976;12:180-91.
30. Tozawa E, Ajioka Y, Watanabe H, Nishikura K, Mukai G, Suda T et al. Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity? Pathol Res Pract 2007;203:567-74.
31. Tsuiji H, Nakatsugawa S, Ishigaki T, Irimura T. Malignant and other properties of human colon carcinoma cells after suppression of sulfomucin production in vitro. Clin Exp Metastasis 1999;17:97-104.
32. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006;131:117-29.
33. van Klinken BJ, Oussoren E, Weenink JJ, Strous GJ, Büller HA, Dekker J et al. The human intestinal cell lines Caco-2 and LS174T as models to study cell-type specific mucin expression. Glycoconj J 1996;13:757-68.
34. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S et al. Colorectal cancer in mice genetically deficient in the mucin MUC2. Science 2002;295:1726-9.
35. Xie L, Villeneuve PJ, Shaw A. Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int J Oncol 2009;34:1109-15.
36. Yang K, Popova NV, Yang WC, Lozonschi I, Tadesse S, Kent S et al. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Res 2008;68:7313-22.
37. Yonezawa S, Sueyoshi K, Nomoto M, Kitamura H, Nagata K, Arimura Y et al. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. Hum Pathol 1997;28:344-52.